Screenings are a routine method for detecting several types of cancer. However, a recent study suggests there are better techniques to detect cervical and ovarian cancers than methods used in the past.
“For years, women have been going in for annual pap smears to screen for cervical cancer caused by the human papillomavirus,” said Dr. Natalie Gould, Gynecological Oncologist at The Women’s Cancer Center of Nevada (WCC). “Now women have the option of taking a single HPV test to determine their risk.”
According to research conducted by Kaiser Permanente health care system, an HPV test is better than a pap smear to identify women who are at high-risk. These findings also determined women who test negative for HPV only need a pap smear every three years, saving cost and anxiety.
“Although we believe in early detection, ovarian cancer often spreads before it is detected,” said Dr. Gould.
In addition, the National Cancer Institute (NCI) examined the accuracy of screening for ovarian cancer with a blood test for a marker known as CA-125 in conjunction with a vaginal ultrasound. The results found no evidence to support the number of deaths from the disease in women who received annual screening and those who received standard care.
Both studies will be discussed in further detail at the American Society of Clinical Oncology’s (ASCO) annual meeting, June 3-7 in Chicago.
For more information about cancer screenings, contact WCC at 702-693-6870 or visit www.wccenter.com
About The Women’s Cancer Center of Nevada
The Women’s Cancer Center of Nevada is the only cancer center in Nevada that specializes exclusively in gynecologic cancers, including ovarian, cervical and uterine cancer. As a full member in the Gynecologic Oncology Group, Women’s Cancer Center offers both standard approaches and clinical trials for those who qualify. Women’s Cancer Center surgeons are pioneers in the research and use of laparoscopic techniques, which, though less invasive, can be as effective as more widely used surgical procedures for treating women with gynecologic cancers. Women’s Cancer Center is one of only a handful of major institutions in the country to study this approach.
The Center is renowned for its treatment of women with advance ovarian cancer and treats patients from all over the United States and the world, including New York, South Carolina, Virginia, Washington DC, Japan, Taiwan, and China. It is one of the few centers to perform liver resection for recurrent ovarian cancer and other secondary debulking surgical procedures. The Center succeeds for women where many others often fail.